% Expired Patents = 33.3

Forward Citations = 47

Loading Chart...

9 inventors (with patents filed for the assignee):

Aquilur Rahman (5 out of 16 patents)

Imran Ahmad (3 out of 32 patents)

Anatoly Dritschilo (1 out of 24 patents)

4. Jia-Ai Zhang (1 out of 2 patents)

5. Usha Kasid (1 out of 10 patents)

6. Prafulla Gokhale (1 out of 6 patents)

7. Aquilar Rahman (1 out of 2 patents)

8. Jin Pei (1 out of 1 patent)

9. Rajshree Mewani (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 7390502 - SN-38 lipid complexes and their methods of use (2008-06-24),

2. 7314637 - Method of administering liposomal encapsulated taxane (2008-01-01),

3. 7262173 - Chemosensitizing with liposomes containing oligonucleotides (2007-08-28),

4. 7122553 - Liposomal formulation of irinotecan (2006-10-17),

5. 6461637 - Method of administering liposomal encapsulated taxane (2002-10-08),

6. 6146659 - Method of administering liposomal encapsulated taxane (2000-11-14),

Company Overview

NeoPharm, Inc. is a biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies for various diseases. With a focus on oncology, we strive to improve patient outcomes through the advancement of targeted therapies and novel drug delivery systems. Our experienced team of scientists and researchers is committed to discovering new treatment options and delivering transformative medicines to patients in need. Visit our website to learn more about our groundbreaking work in the field of biopharmaceuticals.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#3 in Bannockburn, IL

#2,111 in Illinois

#44,981 in US

Bannockburn, IL, United States of America

Neopharm, Inc.

Forward Citations = 47

9 inventors:

Aquilur Rahman (5 out of 16 patents)

Imran Ahmad (3 out of 32 patents)

Anatoly Dritschilo (1 out of 24 patents)

4. Jia-Ai Zhang (1 out of 2 patents)

5. Usha Kasid (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neopharm, Inc.. Retrieved from https://idiyas.com/company/neopharm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]